Scopolamine placebo: Clinical Trials

2 trials of Scopolamine placebo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1

Follow Scopolamine placebo: new trials by email Literature Review of Scopolamine placebo trials Research Report on Scopolamine placebo

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers
BPN14770, BPN14770 placebo, Donepezil - Alzheimer Disease
Phase 1CompletedTetra Discovery Partners382017-01-012018-10-16
TAK-071 Scopolamine-Induced Cognitive Impairment Study
Scopolamine, TAK-071, Donepezil - Healthy Volunteers
Phase 1TerminatedTakeda182016-11-212019-06-14

Conditions studied

Alzheimer Disease (1)  ·  Dementia (1)

Sponsors

Takeda (1)  ·  Tetra Discovery Partners (1)

Countries

United States (2)

Top investigators

Cassandra Key, MD (1)